FDA.reportPublic FDA data

rotigotine 6 MG/Day 24HR Transdermal System

RxCUI
722279
RxNorm name
rotigotine 6 MG/Day 24HR Transdermal System
Display name
rotigotine 6 MG/Day 24HR Transdermal System
Full name
rotigotine 6 MG/Day 24HR Transdermal System
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NeuproROTIGOTINEUCB, Inc.939e28c5-f3a9-42c0-9a2d-8d471d82a6e02025-06-24Warnings, Adverse reactionsExact identifier
rxcui: 722279

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
939e28c5-f3a9-42c0-9a2d-8d471d82a6e0rotigotine 6 MG/Day 24HR Transdermal System [PSN] · 24 HR rotigotine 0.25 MG/HR Transdermal System [SCD] · rotigotine 0.25 MG/HR 24 HR Transdermal Patch [SY] · rotigotine 6 MG/Day 24 HR Transdermal Patch [SY] · rotigotine 6 MG/Day 24HR Transdermal System [SY]520These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 200720250624